# Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)

> **NCT03094663** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 86 (actual)

## Conditions studied

- Knee Arthropathy

## Interventions

- **DRUG:** Bupivacaine with epinephrine
- **DRUG:** Methylprednisolone
- **DRUG:** Cefazolin
- **DEVICE:** 8 MHz. Chiba needle
- **DRUG:** Bupivacaine with Dexamethasone
- **DRUG:** Bupivacaine 25cc
- **DRUG:** Bupivacaine 20cc
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03094663
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-28
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-09-01
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03094663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03094663, "Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03094663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*